Pharmacy

Top Medical News
Saving the heart: “Statins are effective”—supports Malaysian study
an hour ago
Using artificial intelligence-powered software to deliver personalized behavioural nudges helps improve patient adherence to statins, a new trial has found.
Amyloid burden spurs white matter degradation in cognitively normal elderly
19 hours ago
The progression of white matter changes in cerebral small vessel disease does not seem to be different between aspirin- and cilostazol-treated patients, a study has found.
Statins help preserve liver function in chronic liver disease
Pearl Toh, 21 hours ago
Statins can help preserve liver function in patients with chronic liver disease, according to two studies presented at AASLD 2021— showing that not only are statins protective for the heart, but also for the liver.
Does COVID-19 vaccine effectiveness wane over time?
Roshini Claire Anthony, Yesterday

A large study conducted in Israel has suggested that the effectiveness of the BNT162b2 vaccine against COVID-19 decreases over time.

Community pharmacist intervention helps improve medication adherence
Yesterday
A recent collaborative effort has successfully implemented a community pharmacist-led adherence intervention in several independent pharmacies in Buffalo, New York in the US, which has resulted in increased interactions with patients and, in some cases, improved adherence measures, reports a study.
Methylprednisolone improves major kidney outcomes in patients with IgAN
Elaine Soliven, 2 days ago
Treatment with methylprednisolone reduces the risk of kidney composite outcomes, including kidney failure, 40 percent decline in eGFR, or death due to kidney disease, in patients with IgA nephropathy (IgAN), according to the TESTING* study presented at ASN Kidney Week 2021.
6-month single antiplatelet regimen after DAPT post-PCI may reduce GI injury
Roshini Claire Anthony, 2 days ago

Among patients who received 6 months of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), switching to a single antiplatelet therapy (SAPT) regimen for another 6 months resulted in less gastrointestinal (GI) injury than continuing DAPT, results of the OPT-PEACE trial showed.

Special Reports
NOACs in nonvalvular atrial fibrillation with multimorbidity: Where does apixaban stand?
02 Nov 2021
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice, affecting millions of people globally. Stroke is one of its devastating complications, with the risk steeply increasing with advancing age. Additionally, AF is associated with more than a tripling of the risk of systemic embolic (SE) events. [J Am Heart Assoc 2020;9:e016724]
Kids hard-hit by Delta; which ART performs best?
Elvira Manzano, 24 Oct 2021
That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.
Rapid antigen test: Don’t let perfect be the enemy of good
Pearl Toh, 23 Oct 2021
While rapid antigen test is less sensitive than conventional nucleic acid amplification test (NAAT) such as RT-PCR* in detecting SARS-CoV-2 virus, “a test does not have to be perfect to be clinically useful,” said Professor Angela Caliendo during a session in IDWeek 2021 — echoing the maxim that perfect should not be the enemy of good in the pandemic era.
ID NOW rapid molecular assay an effective COVID-19 test for kids
Roshini Claire Anthony, 20 Oct 2021

A large retrospective study from the US, presented at IDWeek 2021, has shown that the Abbott ID NOW rapid molecular COVID-19 assay is highly sensitive and specific at detecting SARS-CoV-2 infection in a paediatric population.

Product Highlight - Lixiana
29 Sep 2021
Edoxaban 30 mg and 60 mg FC tab
Product Highlight - Cresemba
29 Sep 2021
Isavuconazole 100 mg hard cap and 200 mg infusion conc
Product Highlight - Cabometyx
29 Sep 2021
Cabozantinib 60 mg, 40 mg and 20 mg tab
Conference Reports
Statins help preserve liver function in chronic liver disease
Pearl Toh, 27 Nov 2021
Statins can help preserve liver function in patients with chronic liver disease, according to two studies presented at AASLD 2021— showing that not only are statins protective for the heart, but also for the liver.
Methylprednisolone improves major kidney outcomes in patients with IgAN
Elaine Soliven, 26 Nov 2021
Treatment with methylprednisolone reduces the risk of kidney composite outcomes, including kidney failure, 40 percent decline in eGFR, or death due to kidney disease, in patients with IgA nephropathy (IgAN), according to the TESTING* study presented at ASN Kidney Week 2021.
6-month single antiplatelet regimen after DAPT post-PCI may reduce GI injury
Roshini Claire Anthony, 25 Nov 2021

Among patients who received 6 months of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), switching to a single antiplatelet therapy (SAPT) regimen for another 6 months resulted in less gastrointestinal (GI) injury than continuing DAPT, results of the OPT-PEACE trial showed.

Lumasiran reduces plasma oxalate in advanced PH1
Elvira Manzano, 25 Nov 2021
Treatment with the RNAi therapeutic lumasiran led to a significant reduction in plasma oxalate and pre-dialysis oxalate levels in patients with advanced primary hyperoxaluria type 1 (PH1), according to the 6-month primary analysis of phase III ILLUMINATE-C trial presented at ASN Kidney Week 2021.
Oral daprodustat on par with ESA for anaemia in CKD
Pearl Toh, 24 Nov 2021
The oral HIF-PHI* daprodustat was noninferior to standard treatment with erythropoiesis-stimulating agents (ESAs) for increasing haemoglobin levels to within target range, without increasing cardiovascular (CV) risk in patients with anaemia due to chronic kidney disease (CKD), regardless of whether they were dialysis dependent or not, according to the phase III ASCEND-D/-ND trials presented at ASN 2021.
Dupilumab benefits in EoE sustained through 52 weeks
Pearl Toh, 23 Nov 2021
The anti–interleukin (IL)-4/-13 antibody dupilumab led to sustained improvements across symptomatic, histologic, and endoscopic measures of eosinophilic oesophagitis (EoE) out to 52 weeks, according to additional data from the LIBERTY EoE TREET trial presented at ACG 2021.
Bempedoic acid improves lipid, glycaemic parameters regardless of metabolic status
Audrey Abella, 22 Nov 2021
Data presented at AHA 2021 demonstrated the efficacy and safety of bempedoic acid for improving lipid and glycaemic parameters and hsCRP irrespective of metabolic status.
Product Highlights
CME Modules